Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related

Breast Cancer Research

Volumn 6, Issue 4, 2004, Pages

  Bos, Reinhard ^a   van Diest, Paul J ^b   van der Groep, Petra ^b   Shvarts, Avi ^b   Greijer, Astrid E ^a   van der Wall, Elsken ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bcl 2; breast cancer; estrogen receptor; hypoxia inducible factor 1 ; p53

Indexed keywords

CELL CYCLE PROTEIN; ESTROGEN RECEPTOR; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTION FACTOR;

ANOXIA; ARTICLE; BREAST TUMOR; CANCER INVASION; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE; PAGET NIPPLE DISEASE; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ANOXIA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL CYCLE PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPH NODES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS;

EID: 7044271020     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr813     Document Type: Article

References (48)

1. G.L. Semenza G.L. Wang A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation Mol Cell Biol 1992 12 5447 5454 1:CAS:528:DyaK3sXltFShsr0%3D 10.1128/MCB.12.12.5447 1448077 360482
2. B.H. Jiang E. Rue G.L. Wang R. Roe G.L. Semenza Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1 J Biol Chem 1996 271 17771 17778 1:CAS:528:DyaK28XksFyit70%3D 10.1074/jbc.271.30.17771 8663540
3. L.E. Huang Z. Arany D.M. Livingston H.F. Bunn Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit J Biol Chem 1996 271 32253 32259 1:CAS:528:DyaK2sXit1ehsA%3D%3D 10.1074/jbc.271.50.32253 8943284
4. 2tension Am J Physiol 1996 271 C1172 C1180 1:CAS:528:DyaK28XmsF2nurw%3D 8897823
5. 2homeostasis by hypoxia-inducible factor 1 Annu Rev Cell Dev Biol 1999 15 551 578 1:CAS:528:DC%2BD3cXhtVSnu70%3D 10.1146/annurev.cellbio.15.1.551 10611972
6. P.J. Ratcliffe J.F. O'Rourke P.H. Maxwell C.W. Pugh Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression J Exp Biol 1998 201 1153 1162 1:CAS:528:DyaK1cXjvVOgs70%3D 9510527
7. W. Zundel C. Schindler D. Haas-Kogan A. Koong F. Kaper E. Chen A.R. Gottschalk H.E. Ryan R.S. Johnson A.B. Jefferson D. Stokoe A.J. Giaccia Loss of PTEN facilitates HIF-1-mediated gene expression Genes Dev 2000 14 391 396 1:CAS:528:DC%2BD3cXhsFCgt7w%3D 10691731 316386
8. R. Ravi B. Mookerjee Z.M. Bhujwalla C.H. Sutter D. Artemov Q. Zeng L.E. Dillehay A. Madan G.L. Semenza A. Bedi Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α Genes Dev 2000 14 34 44 1:CAS:528:DC%2BD3cXntFGkuw%3D%3D 10640274 316350
9. E. Laughner P. Taghavi K. Chiles P.C. Mahon G.L. Semenza Her2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (hif-1α) synthesis: novel mechanism for hif-1-mediated vascular endothelial growth factor expression Mol Cell Biol 2001 21 3995 4004 1:CAS:528:DC%2BD3MXktFWgtL4%3D 10.1128/MCB.21.12.3995-4004.2001 11359907 87062
10. R. Bos H. Zhong C.F. Hanrahan E.C. Mommers G.L. Semenza H.M. Pinedo M.D. Abeloff J.W. Simons P.J. van Diest E. van der Wall Levels of hypoxia-inducible factor-1α during breast carcinogenesis J Natl Cancer Inst 2001 93 309 314 1:STN:280:DC%2BD3M7psFCgsA%3D%3D 10.1093/jnci/93.4.309 11181778
11. R. Bos P. van der Groep A.E. Greijer A. Shvarts S. Meijer H.M. Pinedo G.L. Semenza P.J. van Diest E. van der Wall Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma Cancer 2003 97 1573 1581 10.1002/cncr.11246 12627523
12. P.J. van Diest J.P. Baak The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients Hum Pathol 1991 22 326 330 1:STN:280:DyaK3M3mslGhsQ%3D%3D 10.1016/0046-8177(91)90080-9 2050366
13. C.W. Elston I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 1991 19 403 410 1:STN:280:DyaK38%2FpvVSltw%3D%3D 10.1111/j.1365-2559.1991.tb00229.x 1757079
14. P.J. van Diest No consent should be needed for using leftover body material for scientific purposes BMJ 2002 325 648 651 10.1136/bmj.325.7365.648 12242180
15. M.N. Bobrow G.J. Litt K.J. Shaughnessy P.C. Mayer J. Conlon The use of catalyzed reporter deposition as a means of signal amplification in a variety of formats J Immunol Methods 1992 150 145 149 1:CAS:528:DyaK38XlsVKlt7Y%3D 10.1016/0022-1759(92)90073-3 1613251
16. E.C. Mommers A.M. Leonhart F. Falix R. Michalides C.J. Meijer J.P. Baak P.J. Diest Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade J Pathol 2001 194 327 333 1:STN:280:DC%2BD3MzosFensQ%3D%3D 10.1002/path.910 11439365
17. 1/S transition and leads to premature activation of cycl Mol Cell Biol 1999 19 6183 6194 1:CAS:528:DyaK1MXlslWjsb0%3D 10.1128/MCB.19.9.6183 10454565 84557
18. R. Michalides H. van Tinteren A. Balkenende J.B. Vermorken J. Benraadt J. Huldij P. van Diest Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment Br J Cancer 2002 86 402 408 1:CAS:528:DC%2BD38XisFOls78%3D 10.1038/sj.bjc.6600072 11875707 2375223
19. I.R. Bukholm G. Bukholm J.M. Nesland Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas Int J Cancer 2001 93 283 287 1:STN:280:DC%2BD3MzkslCitA%3D%3D 10.1002/ijc.1311 11410878
20. P.J. van Diest G. Brugal J.P. Baak Proliferation markers in tumours: interpretation and clinical value J Clin Pathol 1998 51 716 724 1:STN:280:DyaK1M7kslCisQ%3D%3D 10.1136/jcp.51.10.716 10023332 500923
21. P. Carmeliet Y. Dor J.M. Herbert D. Fukumura K. Brusselmans M. Dewerchin M. Neeman F. Bono R. Abramovitch P. Maxwell C.J. Koch P. Ratcliffe L. Moons R.K. Jain D. Collen E. Keshert E. Keshet Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Nature 1998 394 485 490 1:CAS:528:DyaK1cXltVGqsbg%3D 10.1038/28867 9697772
22. H. Zhong A.M. De Marzo E. Laughner M. Lim D.A. Hilton D. Zagzag P. Buechler W.B. Isaacs G.L. Semenza J.W. Simons Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases Cancer Res 1999 59 5830 5835 1:CAS:528:DyaK1MXnslygsr0%3D 10582706
23. R. Bos P.J. van Diest G.P. van der A.E. Greijer M.A. Hermsen I. Heijnen G.A. Meijer J.P. Baak H.M. Pinedo W.E. van der A. Shvarts Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1α (HIF-1α) Oncogene 2003 22 8948 8951 1:CAS:528:DC%2BD3sXpsVGhsbk%3D 10.1038/sj.onc.1206995 14654791
24. D. Feldser F. Agani N.V. Iyer B. Pak G. Ferreira G.L. Semenza Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2 Cancer Res 1999 59 3915 3918 1:CAS:528:DyaK1MXlsVOlt70%3D 10463582
25. P.H. Maxwell M.S. Wiesener G.W. Chang S.C. Clifford E.C. Vaux M.E. Cockman C.C. Wykoff C.W. Pugh E.R. Maher P.J. Ratcliffe The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 1999 399 271 275 1:CAS:528:DyaK1MXjsFyqt74%3D 10.1038/20459 10353251
26. H. Zhong K. Chiles D. Feldser E. Laughner C. Hanrahan M.M. Georgescu J.W. Simons G.L. Semenza Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics Cancer Res 2000 60 1541 1545 1:CAS:528:DC%2BD3cXit1aqt74%3D 10749120
27. F. Rose F. Grimminger J. Appel M. Heller V. Pies N. Weissmann L. Fink S. Schmidt S. Krick G. Camenisch M. Gassmann W. Seeger J. Hanze Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells: role of hypoxia-inducible transcription factors FASEB J 2002 16 1660 1661 1:CAS:528:DC%2BD38XnvFWgurs%3D 12207001
28. N. Goda H.E. Ryan B. Khadivi W. McNulty R.C. Rickert R.S. Johnson Hypoxia-inducible factor 1α is essential for cell cycle arrest during hypoxia Mol Cell Biol 2003 23 359 369 1:CAS:528:DC%2BD3sXhtVOrug%3D%3D 10.1128/MCB.23.1.359-369.2003 12482987 140666
29. J.S. de Jong P.J. van Diest R.J. Michalides J.P. Baak Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas Mol Pathol 1999 52 78 83 1:CAS:528:DyaK1MXislKktbk%3D 10.1136/mp.52.2.78 10474686 395678
30. E. Sivridis A. Giatromanolaki K.C. Gatter A.L. Harris M.I. Koukourakis Association of hypoxia-inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma Cancer 2002 95 1055 1063 1:CAS:528:DC%2BD38XntlSrtLk%3D 10.1002/cncr.10774 12209691
31. M. Schindl S.F. Schoppmann H. Samonigg H. Hausmaninger W. Kwasny M. Gnant R. Jakesz E. Kubista P. Birner G. Oberhuber Overexpression of hypoxia-inducible factor 1α is associated with an unfavorable prognosis in lymph node-positive breast cancer Clin Cancer Res 2002 8 1831 1837 1:CAS:528:DC%2BD38Xlt1Crtbs%3D 12060624
32. N.J. Mabjeesh M.T. Willard C.E. Frederickson H. Zhong J.W. Simons Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells Clin Cancer Res 2003 9 2416 2425 1:CAS:528:DC%2BD3sXlt1ykur0%3D 12855613
33. K. Helczynska A. Kronblad A. Jogi E. Nilsson S. Beckman G. Landberg S. Pahlman Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ Cancer Res 2003 63 1441 1444 1:CAS:528:DC%2BD3sXisFaisrY%3D 12670886
34. M. Stoner B. Saville M. Wormke D. Dean R. Burghardt S. Safe Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells Mol Endocrinol 2002 16 2231 2242 1:CAS:528:DC%2BD38XnsFKmu78%3D 10.1210/me.2001-0347 12351689
35. W.G. An M. Kanekal M.C. Simon E. Maltepe M.V. Blagosklonny L.M. Neckers Stabilization of wild-type p53 by hypoxia-inducible factor 1α Nature 1998 392 405 408 1:CAS:528:DyaK1cXitlShur8%3D 10.1038/32925 9537326
36. J.P. Piret D. Mottet M. Raes C. Michiels Is HIF-1α a pro- or an anti-apoptotic protein? Biochem Pharmacol 2002 64 889 892 1:CAS:528:DC%2BD38Xms1yms7w%3D 10.1016/S0006-2952(02)01155-3 12213583
37. R.K. Bruick Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia Proc Natl Acad Sci USA 2000 97 9082 9087 1:CAS:528:DC%2BD3cXls12ksrg%3D 10.1073/pnas.97.16.9082 10922063 16825
38. M.V. Blagosklonny W.G. An L.Y. Romanova J. Trepel T. Fojo L. Neckers p53 inhibits hypoxia-inducible factor-stimulated transcription J Biol Chem 1998 273 11995 11998 1:CAS:528:DyaK1cXjtlSgs7o%3D 10.1074/jbc.273.20.11995 9575138
39. B. Linderholm B. Lindh B. Tavelin K. Grankvist R. Henriksson p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma Int J Cancer 2000 89 51 62 1:CAS:528:DC%2BD3cXhsVGqsLk%3D 10.1002/(SICI)1097-0215(20000120)89:1<51::AID-IJC9>3.0.CO;2-8 10719731
40. P. Birner M. Schindl A. Obermair G. Breitenecker G. Oberhuber Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy Clin Cancer Res 2001 7 1661 1668 1:CAS:528:DC%2BD3MXltV2hs74%3D 11410504
41. P.J. van Diest R.J. Michalides L. Jannink V. van d H.L. Peterse J.S. de Jong C.J. Meijer J.P. Baak Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value Am J Pathol 1997 150 705 711 1:CAS:528:DyaK2sXhtlSktr8%3D 9033283 1858273
42. R.M. Zwijsen E. Wientjens R. Klompmaker S.J. van der R. Bernards R.J. Michalides CDK-independent activation of estrogen receptor by cyclin D1 Cell 1997 88 405 415 1:CAS:528:DyaK2sXhtFagtbw%3D 10.1016/S0092-8674(00)81879-6 9039267
43. R.S. Bindra J.R. Vasselli R. Stearman W.M. Linehan R.D. Klausner VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells Cancer Res 2002 62 3014 3019 1:CAS:528:DC%2BD38XksVyru78%3D 12036906
44. A. Iervolino D. Trisciuoglio D. Ribatti A. Candiloro A. Biroccio G. Zupi D. Del Bufalo Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity FASEB J 2002 16 1453 1455 1:CAS:528:DC%2BD38XntV2qtLk%3D 12205045
45. G.P. Pidgeon M.P. Barr J.H. Harmey D.A. Foley D.J. Bouchier-Hayes Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells Br J Cancer 2001 85 273 278 1:CAS:528:DC%2BD3MXmtVKhtL0%3D 10.1054/bjoc.2001.1876 11461089 2364032
46. E. Villar M. Redondo I. Rodrigo J. Garcia E. Avila A. Matilla bcl-2 expression and apoptosis in primary and metastatic breast carcinomas Tumour Biol 2001 22 137 145 1:CAS:528:DC%2BD3MXjtFyjuro%3D 10.1159/000050608 11275791
47. R. Bos P.J. van Diest E. van der Wall Response: Re: levels of hypoxia-inducible factor-1 during breast carcinogenesis J Natl Cancer Inst 2001 93 1177 1177 10.1093/jnci/93.15.1177
48. H.M. Sowter P.J. Ratcliffe P. Watson A.H. Greenberg A.L. Harris HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors Cancer Res 2001 61 6669 6673 1:CAS:528:DC%2BD3MXntFaisrc%3D 11559532